Innovators, In all places! LymeX Diagnostics Prize Attracts Over 50

The U.S. Division of Well being and Human Companies and the Steven & Alexandra Cohen Basis (Cohen Basis) introduced that the LymeX Diagnostics Prize acquired 52 Part 1 submissions. From Could to August 2022, the primary part of this Lyme Innovation Accelerator competitors referred to as on consultants to submit revolutionary detection strategies that may advance Lyme illness diagnostics. Hailing from a spread of organizations—together with academia, innovation facilities, main diagnostics firms, and startup labs—entrants submitted a breadth of proposed options for detecting lively Lyme illness infections in folks. The last word purpose of the multiphase competitors is to nurture the event of diagnostics towards Meals and Drug Administration overview.

Though an estimated 476,000 Americans are identified and handled for Lyme every year, there isn’t a FDA-cleared check that may detect lively an infection. Early analysis of Lyme illness is crucial: if left untreated, the debilitating illness can grow to be more durable to eradicate and might unfold all through the physique. By utilizing an open innovation construction, the LymeX Diagnostics Prize is ready to provide funding alongside entry to technical help whereas fostering collaboration alternatives—which offers incentives to a various group of consultants to return collectively and deal with an unmet affected person want. From adapting methods corresponding to radiology imaging, genomics sequencing, and microfluidics to translating approaches utilized in diagnosing different infectious ailments, together with COVID-19, the idea papers that have been submitted proposed a spread of high-potential concepts.

It’s a precedence for this administration to guard and increase People’ entry to high quality, inexpensive well being care. The success of Part 1 of the LymeX Diagnostics Prize competitors has the potential to handle People’ crucial want for an correct Lyme illness diagnostic check.  Part 1 demonstrated that the competitors’s open innovation mannequin can speed up scientific breakthroughs whereas fostering collaboration and partnerships.

A multidisciplinary group of technical reviewers and judges are evaluating submissions based on official Part 1 evaluation criteria. Based mostly on this analysis, the judging panel will advocate as much as 10 winners, who will every obtain an equal share of the $1 million Part 1 prize pool and an invite to take part in a proposed Part 2.

“We’re thrilled by the big selection of options and stay up for working with the LymeX Diagnostics Prize’s neighborhood of collaborators to advance the subsequent technology of Lyme illness diagnostics,” mentioned Steven & Alexandra Cohen Basis President Alexandra Cohen. “By way of our $10 million pledge to the prize competitors, we’re dedicated to strengthening our public-private LymeX partnership with HHS.”

On the discretion of HHS and the Cohen Basis, and topic to availability of future funding, no less than one further part could comply with Part 2. Future phases are anticipated to give attention to scientific and nonclinical validation of diagnostic assessments that detect lively an infection by Lyme-disease-causing micro organism, in addition to readiness for regulatory submission and market entry. Because of a $10 million pledge to the LymeX Diagnostics Prize from the Cohen Basis, $9 million in further LymeX prizes are projected to be obtainable in proposed future phases.

To study extra, go to and subscribe to the competition newsletter.

About LymeX
The LymeX Diagnostics Prize is sponsored by the Lyme Innovation Accelerator, a partnership between the U.S. Division of Well being and Human Companies and the Steven & Alexandra Cohen Basis. LymeX is the world’s largest public-private partnership for Lyme illness, fostering collaborative innovation amongst sufferers and advocates, academia, nonprofits, trade, and authorities. As a element of a bigger moonshot, LymeX is figuring out, creating, and implementing developments in Lyme illness care. Along with accelerating next-generation diagnostics, LymeX is spearheading improvement of human-centered options and fostering breakthroughs in training and consciousness. For extra data, go to

In regards to the U.S. Division of Well being and Human Companies
HHS enhances and protects the well being and well-being of all People. HHS fulfills that mission by offering for efficient well being and human companies and by fostering sound, sustained advances within the sciences underlying medication, public well being, and social companies. For extra data, go to

In regards to the Steven & Alexandra Cohen Basis
The Steven & Alexandra Cohen Basis is dedicated to inspiring philanthropy and neighborhood service by creating consciousness, providing steering, and main by instance to indicate the world what giving can do. The Basis’s grants help nonprofit organizations based mostly in the USA that both assist folks in want or resolve advanced issues. The Basis is the most important non-public funder of Lyme and tick-borne illness analysis in the USA with over $75 million disbursed for groundbreaking research in prevention, diagnostics, and remedy in addition to constructing important analysis infrastructure to catalyze innovation. The Basis additionally spearheads grassroots campaigns to encourage others to offer. For extra data, go to